Cns Pharmaceuticals 

€0.5900
88
-€0.08-11.94% Monday 06:06

Statistics

Day High
0.65
Day Low
0.65
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

18AugExpected
Q3 2024
Q1 2025
Q2 2025
-21.45
-15.88
-10.31
-4.75
Expected EPS
-8.40288
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-2.48MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Monumental Minerals Corp., an exploration stage company, engages in the acquisition and exploration of mineral properties in Canada and Mexico, and Chile. It has an option to acquire 100% interest in the Jemi Project consisting of 6 mineral concessions comprising approximately 3,560 hectares located in the Ocampo municipality of Coahuila State, Mexico; a 75% interest in the Laguna Project that covers 5200-hectares located near the town of San Pedro de Atacama, Chile; and a 50.01% interest in the Turi project located within the Lithium triangle northeast from the city of Calama, Chile. The company was formerly known as Monumental Gold Corp. and changed its name to Monumental Minerals Corp. in November 2021. Monumental Minerals Corp. was incorporated in 2020 and is headquartered in Vancouver, Canada.
Show more...
CEO
Country
Germany
ISIN
US18978H4092
WKN
000A41140

Listings

0 Comments

Share your thoughts

FAQ

What is Cns Pharmaceuticals stock price today?
The current price of BE5.F is €0.59 EUR — it has decreased by -11.94% in the past 24 hours. Watch Cns Pharmaceuticals stock price performance more closely on the chart.
What is Cns Pharmaceuticals stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Cns Pharmaceuticals stocks are traded under the ticker BE5.F.
What is Cns Pharmaceuticals revenue for the last year?
Cns Pharmaceuticals revenue for the last year amounts to 0 EUR.
What is Cns Pharmaceuticals net income for the last year?
BE5.F net income for the last year is -2.48M EUR.
In which sector is Cns Pharmaceuticals located?
Cns Pharmaceuticals operates in the Materials sector.
When did Cns Pharmaceuticals complete a stock split?
Cns Pharmaceuticals has not had any recent stock splits.